Roslin Technologies launches new portfolio company Vetsina
Roslin Technologies, the UK’s specialist AgTech venture builder, is delighted to announce that it is investing in a new portfolio company Vetsina Animal Diagnostics.
The new company is a joint venture with Destina Genomics, an Edinburgh- and Granada, Spain-based diagnostics company. Vetsina, which will be based in Roslin, is developing solutions centred on microRNAs, the speed of testing, and the ability to test for disease closer to where animals and farms are based. The technology will help farmers and veterinarians diagnose infections, illnesses and disease more easily, locally and more cost effectively. The technology will ultimately help with the early diagnosis of infections, enabling more rapid and effective treatment of livestock and companion animals.
The investment is part of Roslin Technologies’ strategy of marrying locally developed IP with the expertise of specialist partners around the world to bring innovative solutions to the veterinary and agri markets. Among our other portfolio companies are those focusing on stem cells, breeding programmes and insect-based nutrition.